{
    "name": "nusinersen",
    "comment": "Rx",
    "other_names": [
        "Spinraza"
    ],
    "classes": [
        "Neurologics",
        "Antisense Oligonucleotides"
    ],
    "source": "https://reference.medscape.com/drug/spinraza-nusinersen-1000135",
    "pregnancy": {
        "common": [
            "There are no adequate data on the developmental risk associated with use in pregnant women",
            "No adverse effects on embryofetal development were observed in animal studies in which nusinersen was administered by subcutaneous injection to mice and rabbits during pregnancy"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Unknown if distributed in human breast milk; detected in milk of lactating mice when administered by subcutaneous injection",
            "Consider the developmental and health benefits of breastfeeding along with the motherâ€™s clinical need for the drug, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": [
                {
                    "type": "Coagulation",
                    "description": [
                        "Coagulation abnormalities and thrombocytopenia, including acute severe thrombocytopenia, have been observed after administration of some antisense oligonucleotides",
                        "Because of risk of thrombocytopenia and coagulation abnormalities, patients may be at increased risk of bleeding complications",
                        "Obtain platelet count and coagulation laboratory testing at baseline and prior to each administration and as clinically needed"
                    ]
                },
                {
                    "type": "Renal toxicity",
                    "description": [
                        "Nusinersen is present in and excreted by the kidney",
                        "Renal toxicity, including potentially fatal glomerulonephritis, has been observed after administration of some antisense oligonucleotides",
                        "Conduct quantitative spot urine protein testing (preferably using a first-morning urine specimen) at baseline and prior to each dose",
                        "For urinary protein concentration >0.2 g/L, consider repeat testing and further evaluation"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Data are from controlled study in infants",
            "percent": "50"
        },
        {
            "name": "Headache",
            "percent": "43"
        },
        {
            "name": "Lower respiratory infection",
            "percent": "41"
        },
        {
            "name": "Back pain",
            "percent": "41"
        },
        {
            "name": "Postlumbar puncture syndrome",
            "percent": "39"
        },
        {
            "name": "Upper respiratory infection",
            "percent": "33"
        },
        {
            "name": "Elevated urine protein",
            "percent": "30"
        },
        {
            "name": "Constipation",
            "percent": "14"
        },
        {
            "name": "Atelectasis",
            "percent": "11"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "6"
        },
        {
            "name": "Upper respiratory tract congestion",
            "percent": "5"
        },
        {
            "name": "Aspiration",
            "percent": "5"
        },
        {
            "name": "Ear infection",
            "percent": "4"
        },
        {
            "name": "Emergent treatment antidrug antibodies",
            "percent": null
        },
        {
            "name": "Hydrocephalus",
            "percent": null
        },
        {
            "name": "Aseptic meningitis",
            "percent": null
        },
        {
            "name": "Hypersensitivity reactions",
            "percent": null
        },
        {
            "name": "e",
            "percent": null
        },
        {
            "name": "g",
            "percent": null
        },
        {
            "name": "angioedema",
            "percent": null
        },
        {
            "name": "urticaria",
            "percent": null
        },
        {
            "name": "rash",
            "percent": null
        }
    ]
}